Expertise in
12
conditions

Dr. Rebecca C. Arend

Oncology
Office
1700 6th Ave S, 
Irondale, AL 
Accepting New Patients
Offers Telehealth
18 Years of Experience
Expertise in
12
conditions
Office
1700 6th Ave S, 
Irondale, AL 

Overview

Rebecca Arend is an Oncologist practicing medicine in Irondale, Alabama. She has been practicing medicine for over 18 years.

Dr. Arend is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor.

She is actively involved in clinical research, co-authoring 155 peer reviewed articles and participating in 8 clinical trials. Dr. Arend is currently accepting new patients.

Graduate Year

2008

Specialties

Oncology

Licenses

Obstetrics & Gynecology in AL

Hospital Affiliations

University Of Alabama Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

Office
1700 6th Ave S, Irondale, AL 35210

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase II, Single Arm Study of Atezolizumab + Bevacizumab in Women With Advanced, Recurrent or Persistent Endometrial Cancer
A Phase II, Single Arm Study of Atezolizumab + Bevacizumab in Women With Advanced, Recurrent or Persistent Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2026
Intervention Type: Drug
Study Drugs: Bevacizumab, Atezolizumab
Study Phase: Phase 2
Trial of M4344 and Niraparib in Patients With PARP Resistant Recurrent Ovarian Cancer
Trial of M4344 and Niraparib in Patients With PARP Resistant Recurrent Ovarian Cancer
Enrollment Status: Withdrawn
Publish Date: June 05, 2026
Intervention Type: Drug
Study Drug: M4344+Niraparib
Study Phase: Phase 1
Pilot Study of Daily Exemestane in Women With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Pilot Study of Daily Exemestane in Women With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Enrollment Status: Completed
Publish Date: August 29, 2025
Intervention Type: Other, Drug
Study Drug: Exemestane
Study Phase: Phase 2
A Phase 2 Study Evaluating the Efficacy and Safety of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial, Epithelial Ovarian Cancer, or Carcinosarcoma
A Phase 2 Study Evaluating the Efficacy and Safety of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial, Epithelial Ovarian Cancer, or Carcinosarcoma
Enrollment Status: Completed
Publish Date: August 01, 2025
Intervention Type: Drug
Study Drugs: Paclitaxel, DKN-01
Study Phase: Phase 2
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Upifitamab rilsodotin
Study Phase: Phase 1/Phase 2
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drugs: VB-111, Paclitaxel
Study Phase: Phase 3
A Phase II Single Arm Study of Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma
A Phase II Single Arm Study of Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma
Enrollment Status: Withdrawn
Publish Date: February 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase Ib Safety Run-in and Randomized Phase II, Open-label Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of M6620 in Combination With Avelumab and Carboplatin in Comparison to Standard of Care Therapy in Participants With PARPi-resistant Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Phase Ib Safety Run-in and Randomized Phase II, Open-label Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of M6620 in Combination With Avelumab and Carboplatin in Comparison to Standard of Care Therapy in Participants With PARPi-resistant Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Enrollment Status: Completed
Publish Date: November 13, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

155 Total Publications

Residential Context and Survival Disparities in Black and White Women With Ovarian Cancer.
Residential Context and Survival Disparities in Black and White Women With Ovarian Cancer.
Journal: JAMA network open
Published: August 10, 2026
Similar Doctors
Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Office

1700 6th Ave S, 
Irondale, AL 
 (0.1 miles away)
205-934-9999
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Warner Huh is an Oncologist practicing medicine in Irondale, Alabama. Dr. Huh is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Ovarian Cancer, Vaginal Cancer, Tubal Ligation, and Endoscopy. Dr. Huh is currently accepting new patients.

Expertise in
23
conditions
Dr. Andres F. Torres
Hematology | Oncology
Expertise in
23
conditions
Dr. Andres F. Torres
Hematology | Oncology
Referral may be required

UAB Hospital Birmingham

619 19th St S, 
Birmingham, AL 
 (8.0 miles away)
205-996-6074
Languages Spoken:
English
See accepted insurances

Andres Torres is a Hematologist and an Oncologist practicing medicine in Birmingham, Alabama. Dr. Torres is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Breast Cancer, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, and Bone Marrow Aspiration.

Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required

UAB Hospital Birmingham

619 19th St S, 
Birmingham, AL 
 (8.0 miles away)
205-934-4011
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Birrer is an Oncologist practicing medicine in Birmingham, Alabama. He has been practicing medicine for over 44 years. Dr. Birrer is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, and PIK3CA-Related Overgrowth Spectrum. Dr. Birrer is currently accepting new patients.

Frequently Asked Questions about Dr. Rebecca C. Arend

How do I make an appointment with Dr. Rebecca C. Arend?

You can book an appointment with Dr. Rebecca C. Arend by calling their office at 205-934-4986. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rebecca C. Arend a top-rated expert for Ovarian Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rebecca C. Arend is classified as an Elite expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rebecca C. Arend specialize in?

While Dr. Rebecca C. Arend is a Oncology, they have specific expertise in Ovarian Cancer, Endometrial Cancer, and Ovarian Carcinosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Rebecca C. Arend participate in research or clinical trials?

Yes. Dr. Rebecca C. Arend has published 155 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Dr. Rebecca C. Arend's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Rebecca C. Arend accept my insurance?

Dr. Rebecca C. Arend accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 205-934-4986 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Arend's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile